Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Churcher

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitorsIan Churcher, Dirk Beher, Jonathan D Best, et al.
Communications Biology|March 22, 2020
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2Alina Mares, Afjal H Miah, Ian E D Smith, et al.
Nature Communications|October 28, 2025
Mode of action of a DCAF16-recruiting targeted glue that can selectively degrade BRD9Scott J Hughes, Wojciech J Stec, Colin T R Davies, et al.
Nature Chemical Biology|June 16, 2015
Catalytic in vivo protein knockdown by small-molecule PROTACsDaniel P Bondeson, Alina Mares, Ian E D Smith, et al.
Journal of Medicinal Chemistry|June 20, 2015
The Discovery of in Vivo Active Mitochondrial Branched-Chain Aminotransferase (BCATm) Inhibitors by Hybridizing Fragment and HTS HitsSophie M Bertrand, Nicolas Ancellin, Benjamin Beaufils, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Bioorganic & Medicinal Chemistry Letters|November 9, 2005
4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitorsIan Churcher, Dirk Beher, Jonathan D Best, et al.
Communications Biology|March 22, 2020
Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2Alina Mares, Afjal H Miah, Ian E D Smith, et al.
Nature Communications|October 28, 2025
Mode of action of a DCAF16-recruiting targeted glue that can selectively degrade BRD9Scott J Hughes, Wojciech J Stec, Colin T R Davies, et al.
Nature Chemical Biology|June 16, 2015
Catalytic in vivo protein knockdown by small-molecule PROTACsDaniel P Bondeson, Alina Mares, Ian E D Smith, et al.
Journal of Medicinal Chemistry|June 20, 2015
The Discovery of in Vivo Active Mitochondrial Branched-Chain Aminotransferase (BCATm) Inhibitors by Hybridizing Fragment and HTS HitsSophie M Bertrand, Nicolas Ancellin, Benjamin Beaufils, et al.
Pageof 4